Latest Share Chat

REMOVE ADS

Sinclair Pharma Share News (SPH)

Sinclair Pharma Information

There is currently no data for SPH

REMOVE ADS

Sinclair Pharma News

Thursday broker round-up UPDATE

Afren: Morgan Stanley takes target price from 215p to 220p and reiterates an overweight rating. Alent: Bank of America starts with a target price of ...

DS Smith exec raises one million quid to pay taxes

Stephen Dryden, the Finance Director of recycled packaging supplier DS Smith, exercised options in the company on Wednesday and subsequently sold half...

Sinclair IS Pharma joins forces with Biocodex to crack new markets

Sinclair IS Pharma has signed a 10-year deal with Biocodex to expand its dermatology portfolio in Russia, Turkey and Europe's Benelux countries. Bio...

Geronimo Inns MD offloads shares in parent group Young's & Co

Rupert Clevely, the Managing Director of Young's & Co Brewery's Geronimo Inns division, sold nearly half a million pounds-worth of shares in the pubs ...

Friday broker round-up - UPDATE

Aggreko: Jefferies keeps buy rating and 2,800p target; Seymour Pierce keeps buy rating and 2,500p target; Panmure Gordon cuts target from 2,228p to 2,...

Monday broker round-up

Barclays: Liberum Capital upgrades to buy, target lifted from 210p to 245p. British American Tobacco: Investec upgrades to buy. Capital & Counties: ...

Sinclair IS Pharma builds on dermatology portfolio

Sinclair IS Pharma said it had secured a long term distribution agreement for three dermatology products. The 100 year deal with Valeant Pharmaceutic...

Sinclair driven by Asian sales

Pharmaceutical firm Sinclair IS Pharma saw a big jump in revenues in the last year driven by international sales. In a trading statement the firm sai...